Last €51.84 EUR
Change Today +0.29 / 0.56%
Volume 120.7K
FME On Other Exchanges
Symbol
Exchange
OTC US
Xetra
Munich
New York
As of 3:58 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

fresenius medical care ag & (FME) Snapshot

Open
€51.80
Previous Close
€51.55
Day High
€51.93
Day Low
€51.29
52 Week High
01/29/14 - €54.38
52 Week Low
06/9/14 - €46.56
Market Cap
16.1B
Average Volume 10 Days
814.0K
EPS TTM
€3.50
Shares Outstanding
309.8M
EX-Date
05/16/14
P/E TM
19.9x
Dividend
€0.77
Dividend Yield
1.49%
Current Stock Chart for FRESENIUS MEDICAL CARE AG & (FME)

Related News

No related news articles were found.

fresenius medical care ag & (FME) Related Businessweek News

No Related Businessweek News Found

fresenius medical care ag & (FME) Details

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) machines, modular components for dialysis machines, polysulfone dialyzers, bloodlines, HD solutions and concentrates, needles, connectors, machines for water treatment, data administration systems, dialysis chairs, phosphate binders, iron products, and other renal drug products. Further, the company provides peritoneal dialysis systems and solutions for continuous ambulatory peritoneal dialysis and automated peritoneal dialysis therapy; and adsorbers, which are filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies, such as bandages, clamps, and injections. It sells its products to clinics, hospitals, and specialized treatment clinics through direct sales forces, local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

91,542 Employees
Last Reported Date: 05/6/14
Founded in 1996

fresenius medical care ag & (FME) Top Compensated Officers

Chairman of the Management Board for Freseniu...
Total Annual Compensation: $1.7M
Chief Financial Officer of Fresenius Medical ...
Total Annual Compensation: $1.0M
Chief Executive Officer of Fresenius Medical ...
Total Annual Compensation: $1.5M
Chief Executive Officer of Asia Pacific Divis...
Total Annual Compensation: $1.1M
Chief Executive Officer of Global Manufacturi...
Total Annual Compensation: $924.0K
Compensation as of Fiscal Year 2013.

fresenius medical care ag & (FME) Key Developments

Fresenius Medical Care and Aetna Collaborate to Provide Coordinated Care Management for End Stage Renal Disease Patients

Fresenius Medical Care and Aetna announced a collaborative care model designed to improve the quality of care for Aetna's Medicare Advantage members who have end stage renal disease, while lowering health care costs. Fresenius Medical Care North America's (FMCNA) nationally-recognized care management program is accredited by the National Committee for Quality Assurance, and creates a new approach for the overall delivery of care focused squarely on the unique needs of dialysis patients. Through this collaboration, Aetna nurse case managers will work closely with FMCNA staff on quality and care management for Aetna Medicare Advantage members who are receiving care at an FMCNA clinic. Aetna and FMCNA will work together to improve the health outcomes of these patients by boosting adherence to best practices and treatment plans. This collaboration builds upon the relationship between Fresenius Medical Care and Aetna, who continue to expand a joint program to identify Aetna Medicare members with chronic kidney disease, and provide education, training and care management designed to ease what can be a difficult transition to dialysis or pre-transplant care.

Fresenius Medical Care AG & Co. KGAA Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 04:40 PM

Fresenius Medical Care AG & Co. KGAA Presents at 2014 Wells Fargo Healthcare Conference, Jun-17-2014 04:40 PM. Venue: InterContinental Hotel Boston, 510 Atlantic Avenu, Boston, MA 02210, United States. Speakers: Robert Maurice Powell, Chairman of the Management Board for Fresenius Medical Care Management AG and Chief Executive Officer of Fresenius Medical Care Management AG, Terry Morris, VP IR.

Fresenius Medical Care AG & Co. KGAA Announces Increase of Dividend

Fresenius Medical Care AG & Co. KGAA announced that at its AGM held on May 15, 2014 approved its 17th consecutive dividend increase. The dividend will be raised to EUR 0.77 from EUR 0.75 per ordinary share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FME:GR €51.84 EUR +0.29

FME Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $74.69 USD -1.40
CareFusion Corp $43.79 USD -1.15
DaVita HealthCare Partners Inc $70.44 USD -0.88
Terumo Corp ¥2,338 JPY -24.00
Toray Industries Inc ¥695.50 JPY -7.00
View Industry Companies
 

Industry Analysis

FME

Industry Average

Valuation FME Industry Range
Price/Earnings 18.9x
Price/Sales 1.4x
Price/Book 2.2x
Price/Cash Flow 19.3x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE AG &, please visit www.fmc-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.